within Pharmacolibrary.Drugs.C_CardiovascularSystem.C05C_CapillaryStabilizingAgents.C05CA05_Hidrosmin;
model Hidrosmin 
   extends Pharmacolibrary.Drugs.ATC.C.C05CA05;

  annotation(Documentation(
    info ="<html><body><p>Hidrosmin is a semisynthetic flavonoid used as a veno-tonic agent to treat chronic venous insufficiency and hemorrhoids. It has been used for its vasoprotective, anti-inflammatory, and anti-edematous properties. While widely used in some countries, it is not approved by the FDA in the United States.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies or clinical PK parameters for hidrosmin were found as of June 2024; therefore, the following pharmacokinetic parameters are estimated/extrapolated based on similar flavonoid drugs (such as diosmin or hesperidin) in healthy adult volunteers.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Hidrosmin;
